Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05966662 · ClinicalTrials.gov registry record · NA

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

A NA study of Coronary Artery Disease and Myocardial Infarction, sponsored by Shockwave Medical.

Completed
Registry status
NA
Development phase
145
Enrollment target
18
Study locations

NCT05966662 is a NA study of Coronary Artery Disease and Myocardial Infarction that has completed, run by Shockwave Medical. The registered enrollment target is 145 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (89% lower). The trial reports 18 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05966662, a NA study of Coronary Artery Disease and Myocardial Infarction, has completed, sponsored by Shockwave Medical.

COMPLETED
Registry status
NA
Development phase
145 participants
Enrollment target
18
Study locations

Study Summary

This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.

Conditions Studied

Coronary Artery Disease Myocardial Infarction

Interventions

  • DEVICE IVL with Shockwave C2+ 2Hz Coronary IVL Catheter

Study Locations (18)

New York

  • Northwell Health/Lenox Hill - New York
  • St. Francis Hospital - Roslyn

Pennsylvania

  • UPMC Pinnacle Health - Harrisburg
  • WellSpan Health - York - York

Texas

  • Baylor Scott and White Research Institute - Dallas
  • Methodist Hospital - San Antonio

Alabama

  • Heart Center Research - Huntsville

California

  • Scripps Clinic - La Jolla

District of Columbia

  • Medstar Washington Hospital Center - Washington D.C.

Florida

  • Memorial Health - Hollywood

Georgia

  • Wellstar Kennestone Hospital - Marietta

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2023-12-08
Est. Completion 2025-12-19
Phase NA

Sponsor

Shockwave Medical

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05966662

The ClinicalTrials.gov registry entry for NCT05966662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (89% lower). The listed sponsor is Shockwave Medical, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which IVL with Shockwave C2+ 2Hz Coronary IVL Catheter is the first listed.

NCT05966662 reports 18 study locations spanning 15 distinct geographic areas - top geographies include New York, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT05966662 about?

NCT05966662 is a clinical study titled "Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)". This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.

What is the current status of trial NCT05966662?

This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2023-12-08. Estimated completion is 2025-12-19.

What conditions does trial NCT05966662 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Infarction.

What interventions are being tested in trial NCT05966662?

The interventions under investigation include: IVL with Shockwave C2+ 2Hz Coronary IVL Catheter (DEVICE).

Who is sponsoring clinical trial NCT05966662?

This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05966662 being conducted?

This trial has 18 study locations across Alabama, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Myocardial Infarction

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.